Digital Phenotyping Market to Grow with a CAGR of 9.42% through 2031

Escalating Prevalence of Chronic Diseases and Shift Towards Telehealth and Remote Patient Monitoring are expected to drive the Global Digital Phenotyping Market growth in the forecast period, 2026-2031

According to TechSci Research report, “Digital Phenotyping Market – Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2031F”, the Global Digital Phenotyping Market stood at USD 1.83 Billion in 2025 and is anticipated to grow with a CAGR of 9.42% in the forecast period, 2026-2031.

One of the most critical long-term growth drivers is the escalating global prevalence of chronic illnesses and mental health disorders. Conditions such as diabetes, cardiovascular disease, and respiratory disorders continue to impose a heavy burden on healthcare systems worldwide. Simultaneously, mental health issues particularly depression and anxiety are being more widely recognized by both healthcare providers and policymakers, leading to a surge in demand for more efficient and precise methods of monitoring, diagnosis, and treatment. The urgency is evident in global health data, with WHO reporting that noncommunicable diseases killed at least 43 million people in 2021 while nearly 1.1 billion people worldwide were living with a mental disorder, reinforcing the need for scalable and continuous monitoring solutions.

The proliferation of connected health devices including smart wearables, biosensors, and portable monitors has transformed the way clinical and physiological data are captured. These devices enable continuous tracking of vital health indicators such as sleep patterns, heart rate, physical activity, and even biochemical markers like proteins, metabolites, and electrolytes. The integration of these technologies in clinical trials and real-world care settings allows for the identification of novel digital biomarkers and more dynamic patient monitoring, thereby significantly enhancing both diagnostic and prognostic capabilities. As mobile health apps and digital platforms become more deeply embedded in everyday healthcare, they contribute vast, high-frequency datasets that can be mined for predictive health insights. This device-led data expansion is accelerating at scale, as IDC projected worldwide wearable shipments would reach 537.9 million units in 2024, creating a much broader foundation for continuous digital biomarker capture in both research and routine care.

In the near term, the market is being driven by a shift toward preventive and personalized medicine. Both providers and patients are adopting a more proactive stance in managing health risks and tailoring care. Digital phenotyping solutions are uniquely positioned to support this transition by offering real-time monitoring, early detection of symptoms, and individualized treatment pathways. These tools enable a deeper, more granular understanding of patient behavior and health trends outside of clinical settings. This transition is being strengthened by the enormous consumer device ecosystem, with Apple reporting more than 2.5 billion active devices worldwide in early 2026, expanding the practical reach of app-based monitoring and individualized digital engagement.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Digital Phenotyping Market”

The most promising opportunities in the space is the application of artificial intelligence and machine learning. These technologies allow for the analysis of massive, multidimensional data sets generated from smartphones, wearable devices, and electronic health records. By identifying hidden patterns and correlations, AI-driven models can accurately predict health trajectories and deliver actionable insights to clinicians. The convergence of artificial intelligence with digital phenotyping holds the potential to fundamentally reshape disease management and patient engagement strategies. The regulatory momentum behind this opportunity is already visible, with FDA-related reporting showing that more than 1,000 AI-enabled medical devices have moved through established premarket pathways, signaling growing confidence in AI-driven clinical software and data-intensive decision support.

A defining trend shaping the industry is the heightened focus on data privacy and information security. As the volume and sensitivity of personal health data continue to grow, concerns around unauthorized access and misuse have intensified. To address this, digital phenotyping providers are investing in advanced cybersecurity infrastructure, including end-to-end encryption, anonymization protocols, and secure data storage solutions. In parallel, regulatory agencies are rolling out more stringent compliance frameworks to ensure ethical data use and protect patient rights. These developments underscore the industry’s broader commitment to building patient trust and maintaining transparency as digital health tools become more pervasive. This focus is being reinforced by regulation, as the European Commission states that high-risk AI systems intended for medical purposes must meet requirements for risk mitigation, high-quality datasets, clear user information, and human oversight under the AI Act.

The Global Digital Phenotyping Market is segmented into data stream, device type, application, regional distribution, and company.

Based on data stream, the passive data stream segment emerges as the dominant force, both in terms of adoption and market share. This segment includes data automatically captured through smartphones, wearable devices, and other connected technologies such as GPS coordinates, Wi-Fi and Bluetooth connectivity, accelerometer readings, and other sensor-based inputs. The increasing reliance on passive data in clinical research, remote monitoring, and mental health management underscores its growing strategic importance. Its relevance is further amplified by the scale of smartphone dependence, as Eurostat reported that 94% of individuals in the EU used the internet in the prior three months in 2025 and nearly 9 in 10 users went online through smartphones or similar devices, highlighting the readiness of populations for always-on passive sensing models.

Passive data collection offers a major advantage: it does not require active participation from users. Unlike surveys or self-reported inputs that depend on patient compliance and engagement, passive streams operate continuously in the background. This approach significantly reduces patient burden and minimizes data gaps, making it highly scalable across diverse populations. Healthcare providers and researchers can collect longitudinal behavioral and physiological data with minimal disruption to the user’s daily life.

Based on region, the European Digital Phenotyping Market held the second-largest share in the global market and is poised to expand at a significant growth rate during the forecast period. This growth is fueled by the rising demand for mobile health apps and the increased adoption of smartphones and wearable technology in healthcare. Europe is embracing digital phenotyping, leading to opportunities for market growth in the region. The Digital Phenotyping Market in Asia Pacific accounted for a major market share and is anticipated to witness stronger growth during the forecast period. The surge in the usage of smart devices, the proliferation of digital technologies, and the increase in the patient pool are key drivers of market growth in this region. Furthermore, the government’s focus on enhancing healthcare facilities and the growing focus of market players to leverage growth opportunities contribute to the market's expansion. Additionally, the growing geriatric population in Asia Pacific is expected to significantly augment the demand for digital phenotyping. This regional momentum is supported by device adoption trends, with IDC-reported data showing that China shipped 45.8 million wrist-worn devices in the first three quarters of 2024, up 20.1% year over year, underscoring the hardware base supporting broader digital phenotyping uptake across Asia Pacific.

Major companies operating in Global Digital Phenotyping Market are:

• Black Dog Institute
• Mindstrong Inc.
• Sharecare, Inc.
• Alphabet, Inc.
• Onnela lab
• Behavidence

Download Free Sample Report

Customers can also request for 10% free customization on this report.

“The global digital phenotyping market is poised to witness substantial growth in the foreseeable future. This growth can be attributed to the rising adoption of digital health technologies and notable advancements in the fields of artificial intelligence and machine learning. Moreover, the increasing prevalence of chronic diseases and the urgent demand for personalized patient care are expected to further propel the expansion of this market. Additionally, the increasing integration of digital phenotyping into healthcare systems and the potential benefits it offers, such as early disease detection and personalized treatment plans, are anticipated to drive the market's growth trajectory even further. As the digital phenotyping landscape continues to evolve, collaborations between technology providers and healthcare organizations are likely to play a crucial role in shaping the market dynamics and unlocking its full potential.,” said Mr. Karan Chechi, Research Director of TechSci Research, a research-based management consulting firm.

“Digital Phenotyping Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Data Stream (Active {Social Media Activity, Video/Audio Recordings, Survey Responses}, Passive {GPS Coordinates, Wi-Fi, Bluetooth Connectivity, Accelerometer Data, Others}), By Device Type (Smartphones, Wearable Medical Devices, Geophones, Others), By Application (Mood Disorders, Bipolar Disorder, Opioid Overdose Detection, Harmful Alcohol Drinking Behaviour, Others), By Region & Competition, 2020-2031F”, has evaluated the future growth potential of Global Digital Phenotyping Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Digital Phenotyping Market.

Contact

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: [email protected]

Website: www.techsciresearch.com